Advertisement

Oncology

Patient enrollment in clinical trials for cancer therapies has been severely affected by the COVID-19 pandemic, according to an article in the journal Nature Reviews Drug Discovery.

Advertisement

Patient visits for heart attack and stroke have dropped significantly during the COVID-19 pandemic, compared to patient visits during the same period in 2019, indicating patients may be avoiding care for potentially life-threatening conditions, a new study shows.

New York City-based Memorial Sloan Kettering Cancer Center ended the first quarter of 2020 with an operating loss, despite seeing revenue increase year over year, according to recently released financial documents. 

Vaccines and anti-infectives are among the highest therapy priorities for U.S. health plans, according to a report from consulting and professional services firm ZS. 

More than half of cancer researchers report that their work has been temporarily put on hold due to the coronavirus pandemic, according to a new survey.

Advertisement